Oncology Central
  • Home
  • News
  • Insights
    • Insights
      • Opinion
      • Columnists
      • Journal articles
      • Events
      • Spotlights
      • In focus
      • Follow us on social media
    • ADVERT
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
      • Follow us on social media
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • Genetics
      • Preclinical research and trials
      • Prevention and screening
      • Therapies
      • View all
    • ADVERT
  • Multimedia
    • Multimedia
      • Videos
      • Podcasts
      • Infographics
      • Webinars
      • Follow us on social media
    • ADVERT
  • Register
  • i
  • i
  • i
  • Home
  • News
  • Insights
    • Opinion
    • Columnists
    • Journal articles
    • Spotlights
    • In Focus
    • Events
  • Topics
    • Disease area
      • Skin
      • Breast
      • Colorectal
      • Hematologic
      • Lung
      • View all
    • Subject area
      • Immuno-oncology
      • Clinical trials
      • View all
  • Multimedia
    • Videos
    • Infographics
    • Podcasts
    • Webinars
  • Registration
  • Follow us on social media
  • i
  • i

Login

Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.

Forgot your password?

Or register via social media

Already have an account? Login here

Or register via social media

Already have an account? Login here

Most searched
  • ask the experts
  • aacr
  • asco
  • IMpower150
  • research

Industry and Business

  • 23 Jan 2019 News

    Oncology conference and event highlights: January–March 2019

  • 9 Jan 2019 Immuno-oncology

    Our top oncology content of 2018 – a note from the Editor

  • 9 Jan 2019 Cancer biology and pathology

    Clinical trial aims to produce a breath test to identify early-stage cancer

  • 30 Nov 2018 Skin

    PD-1 immunotherapy, nivolumab, made available on the NHS for melanoma patients

  • 27 Nov 2018 Industry and business

    US FDA approves larotrectinib, a unique DNA-targeting drug, for NTRK+ cancers

  • 23 Nov 2018 Lung

    Keytruda® gets the green light from NICE for untreated lung cancer

  • 9 Nov 2018

    NICE recommends new first-line treatment Lenvima against advanced liver cancer

  • 31 Oct 2018 Immuno-oncology

    Plinabulin: a novel immuno-oncology agent for the treatment of chemotherapy-induced neutropenia and advanced NSCLC

  • 29 Oct 2018 Prostate

    Court invalidates patent for prostate cancer drug Zytiga®

  • 24 Oct 2018 Head and neck

    KEYNOTE-048: pembrolizumab changes the rules for head and neck cancer patients

  • 1 Oct 2018 Skin

    FDA approves first and only treatment for advanced cutaneous squamous cell carcinoma

  • 28 Sep 2018 Surgical oncology

    A dog’s 3D printed implant shows potential for cancer surgeries

View More
  • About us
  • Contact Us
  • Our journals
  • Advertising & Sponsorship
  • Ambassadors
  • Twitter
  • Facebook
  • Linkedin
  • RSS
  • Oncology Central Newsletter

    Like our content? Subscribe to our weekly newsletter for news & articles direct to your inbox.


    Stay connected
    • Twitter
    • Facebook
    • Linkedin
    • RSS
  • Find a job

    Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

    Registration

    When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

    Office Info

    Oncology Central is powered by Future Science Group.
    Unitec House, 2 Albert Place, London, N3 1QB, UK,
    +44 (0)20 8371 6090

    • About us
    • Contact Us
    • Our journals
    • Advertising & Sponsorship
    • Ambassadors
    • Find a job

      Connecting talent with opportunity, have a look at our Career Center and find your ideal next career move.

      Registration

      When you create your free account, you will be able to view all articles in full and see content personally tailored for you. Register here.

      Office Info

      Oncology Central is powered by Future Science Group.
      Unitec House, 2 Albert Place, London, N3 1QB, UK,
      +44 (0)20 8371 6090

  • Future Science Group
  • Cookies Policy
  • Privacy Policy
  • Terms & Conditions
  • ©2019 Oncology Central
© 2018 Oncology Central